Surface modification of 3D-printed polycaprolactone-human decellularized bone matrix composite scaffold by plasma for bone tissue engineering
Bioprinting · 2024-12 · 44 · e00378
DOI: 10.1016/j.bprint.2024.e00378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioprinting, 2024-12. Verfasst von Hekmat Farajpour und 3 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Farajpour, H., Ghorbani, M., Moghaddam, M. M., & Goodarzi, V. (2024). Surface modification of 3D-printed polycaprolactone-human decellularized bone matrix composite scaffold by plasma for bone tissue engineering. Bioprinting, 44, e00378. https://doi.org/10.1016/j.bprint.2024.e00378
Vancouver
Farajpour H, Ghorbani M, Moghaddam MM, Goodarzi V. Surface modification of 3D-printed polycaprolactone-human decellularized bone matrix composite scaffold by plasma for bone tissue engineering. Bioprinting. 2024;44:e00378. doi:10.1016/j.bprint.2024.e00378
BibTeX
@article{Farajpour2024,
author = {Farajpour, Hekmat and Ghorbani, Masoud and Moghaddam, Mehrdad Moosazadeh and Goodarzi, Vahabodin},
title = {Surface modification of 3D-printed polycaprolactone-human decellularized bone matrix composite scaffold by plasma for bone tissue engineering},
journal = {Bioprinting},
year = {2024},
volume = {44},
pages = {e00378},
doi = {10.1016/j.bprint.2024.e00378}
}
EUVIMED